MICRO-MEDICAL Instrumente GmbH is primarily active in pharmacies, clinics and the medical trade and imports and trades point-of-care diagnostics as well as sterile and non-sterile medical devices. The product portfolio includes small and medium diagnostic devices, ancillary products for health prevention and service and consulting offerings for medical devices where no special approval is required. In the 2021 fiscal year the company reported revenues of EUR 61.3 million with a net profit of EUR 6,839,698.98 and a gross profit of EUR 11,326,396.82 (18.5% of revenues). The company has pronounced logistical competencies, concluded a master-franchise agreement with an Austrian manufacturer in 2021 and began construction of its own immunanalysis center in 2022. MICRO-MEDICAL Instrumente GmbH is a family business.
der Import und der Handel mit Sofort-Diagnostik (Point-of-Care-Diagnostik) und Medizinprodukten. Zusätzlich werden Beratungsdienstleistungen auf diesen Gebieten angeboten, soweit dafür keine besondere Genehmigungspflicht besteht.
Converted using the official Destatis and Eurostat correspondence tables; ISIC Rev. 4 is the United Nations' international industry classification.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Cottbus Local Court, HRB 13887 (as of 23 October 2026)
| Name | Type | City |
|---|---|---|
| Elisabeth Bruckmoser | Geschäftsführer(in) | Senftenberg OT Niemtsch |
| Horst Bruckmoser | Geschäftsführer(in) | Senftenberg OT Niemtsch |
Source: German Commercial Register (Handelsregister) Cottbus Local Court, HRB 13887 (as of 23 October 2026)
| Date | Event Type | Event |
|---|---|---|
| 03.05.2019 | Business Address Change | Am Neumarkt 2-4, 01968 Senftenberg |
| 31.01.2019 | Company Name Change | MICRO-MEDICAL Instrumente GmbH |
| 31.01.2019 | Gesellschaftsvertrag amended | Gesellschaftsvertrag |
| Date | Type | Change | Total Capital |
|---|---|---|---|
| 27.12.2018 | Share Capital Set | — | 25.000 € |
Source: German Commercial Register (Handelsregister) Cottbus Local Court, HRB 13887 (as of 23 October 2026)
| Year | Revenue | Profit | Balance | Employees |
|---|---|---|---|---|
| 2022 | Rohergebnis€5.7M2 | €2,703,488 | €15,084,464 | 12 |
| 2021 | Rohergebnis€11.3M2 | €6,840,580 | €16,745,711 | 10 |
| 2020 | Rohergebnis€6.2M2 | €3,975,009 | €9,650,275 | 7 |
| 2019 | — | — | €696,704 | — |
1 Small companies are not required to publish a profit-and-loss statement (§ 326 (1) HGB). The figure shown is the statutory ceiling under § 267 HGB where the balance-sheet total makes it binding — a company may exceed at most one of the three size criteria.
2 Rohergebnis nach § 276 HGB: Umsatzerlöse abzüglich Materialaufwand bzw. Herstellungskosten. Kleine und mittelgroße Kapitalgesellschaften dürfen diese Posten zusammenfassen; die Umsatzerlöse selbst sind dann nicht veröffentlicht und liegen über dem Rohergebnis.
Sign in to download data
Source: German Commercial Register (Handelsregister) Cottbus Local Court, HRB 13887 (as of 23 October 2026)
| Cost type | Amount | Share |
|---|---|---|
| Personnel Costs | €744,439 | 85.6% |
| Depreciation | €125,502 | 14.4% |
